Recent data from the Hong Kong Stock Exchange reveals that on May 26, Ariel Investments, LLC increased its holdings in PHARMARON (03759) by 533,400 shares. The transaction was executed at an average price of approximately HK$18.16 per share, amounting to a total investment of about HK$9.689 million. Following this acquisition, Ariel Investments, LLC's total shareholding in the company has risen to 21,306,700 shares, representing a 6.04% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments